Gene Techno Science
Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (8 %) | 57 % | 77 % | (12 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (110 %) | (98 %) | (60 %) | (21 %) | (56 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (679 %) | (100 %) | (34 %) | (24 %) | (58 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 83 % | 97 % | 73 % | 44 % | 60 % |
Source: Company filings or news article
Related Content
G-GTS.com operates in the global trading solutions market, focusing on enhancing supply chain efficiency through advanced technology and data analytics. The company serves a diverse range of clients, including manufacturers, distributors, and retailers, who require streamlined logistics and supply chain management. G-GTS.com leverages a business model that integrates software-as-a-service (SaaS) with data-driven insights to optimize inventory management, reduce operational costs, and improve overall supply chain performance. Revenue is generated through subscription fees for its platform and additional services such as consulting and custom analytics.
Keywords: supply chain, logistics, data analytics, SaaS, inventory management, operational efficiency, global trading, technology, consulting, custom analytics.
Tech stack
Investments by Gene Techno Science
Edit